Key result
Colorectal cancer tissues show significant dysregulation of multiple renin-angiotensin system genes compared to normal tissue.
Why the study?
Recent studies suggest involvement of the renin-angiotensin system in cancers, including colorectal cancer.
Observational (n=148)
Alterations in the expression of renin-angiotensin system genes in colorectal cancer suggest that components of this system may serve as potential therapeutic targets.
These RAS gene expression changes in colorectal cancer are hypothesis-generating; prospective studies needed before considering therapeutic targeting.
Hypothesis/Introduction. Recent studies suggest involvement of the renin-angiotensin system (RAS) in cancers, including colorectal cancer (CRC). This study focuses on the association of genes encoding 17 proteins related to the RAS within a Japanese male CRC population. Materials and Methods. Quantitative expression of the RNA of these 17 genes in normal and cancerous tissues obtained using chip arrays from the public functional genomics data repository, Gene Expression Omnibus (GEO) application, was compared statistically. Results. Expression of four genes, AGT (angiotensinogen), ENPEP (aminopeptidase A) MME (neprilysin), and PREP (prolyl endopeptidase), was significantly upregulated in CRC specimens. Expression of REN (renin), THOP (thimet oligopeptidase), NLN (neurolysin), PRCP (prolyl carboxypeptidase), ANPEP (aminopeptidase N), and MAS1 (Mas receptor) was downregulated in CRC specimens. Conclusions. Presuming gene expression parallel protein expression, these results suggest that increased production of the angiotensinogen precursor of angiotensin (ANG) peptides, with the reduction of the enzymes that metabolize it to ANG II, can lead to accumulation of angiotensinogen in CRC tissues. Downregulation of THOP, NLN, PRCP, and MAS1 gene expression, whose proteins contribute to the ACE2/ANG 1-7/Mas axis, suggests that reduced activity of this RAS branch could be permissive for oncogenicity. Components of the RAS may be potential therapeutic targets for treatment of CRC.
No takes yet. Share an insight, caveat, or question.
Mehranfard et al. (2021) conducted an observational in Colorectal Cancer (n=148). Colorectal cancer vs. Normal colorectal tissue was evaluated on Differential log2 RNA expression of 17 renin-angiotensin system (RAS)-related genes. Colorectal cancer tissues exhibited significant upregulation of AGT, ENPEP, MME, and PREP genes, and downregulation of REN, THOP, NLN, PRCP, ANPEP, and MAS1 genes compared to normal tissues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: